Wireless devices also use haptic feedback to talk to patient
Last summer, Northwestern University scientists introduced the first-ever transient pacemaker — a fully implantable, wireless device that harmlessly dissolves in the body after it’s no longer needed. Now, in a study published in the journal Science, they unveil a new, smart version that is integrated into a coordinated network of four soft, flexible, wireless, wearable sensors and control units placed around the upper body.
The work was led by Northwestern’s John Rogers, PhD, the Louis Simpson and Kimberly Querrey Professor of Materials Science and Engineering, Biomedical Engineering; Igor R. Efimov, PhD, professor at the McCormick School of Engineering; and Rishi Arora, MD, professor of Medicine in the Division of Cardiology.
The sensors communicate with each other to continuously monitor the body’s various physiological functions, including body temperature, oxygen levels, respiration, muscle tone, physical activity and the heart’s electrical activity.
The system then uses algorithms to analyze this combined activity in order to autonomously detect abnormal cardiac rhythms and decide when to pace the heart and at what rate. All this information is streamed to a smartphone or tablet, so physicians can remotely monitor their patients.
The new transient pacemaker and sensor/control network can be used in patients who need temporary pacing after cardiac surgery or are waiting for a permanent pacemaker. The pacemaker wirelessly harvests energy from a node within the network — a small wireless device that softly adheres to the patient’s chest. This technology eliminates the need for external hardware, including wires (or leads).
To enable the system to communicate with the patient, the investigators incorporated a small, wearable haptic-feedback device that can be worn anywhere on the body. When the sensors detect an issue (such as low battery power, incorrect device placement or pacemaker malfunction), the haptic device vibrates in specific patterns that alert wearers and inform them of the problem.
Insights from the experts
“This marks the first time we have paired soft, wearable electronics with transient electronic platforms,” Rogers said. “This approach could change the way patients receive care providing multinodal, closed-loop control over essential physiological processes — through a wireless network of sensors and stimulators that operates in a manner inspired by the complex, biological feedback loops that control behaviors in living organisms.
“For temporary cardiac pacing, the system untethers patients from monitoring and stimulation apparatuses that keep them confined to a hospital setting. Instead, patients could recover in the comfort of their own homes while maintaining the peace of mind that comes with being remotely monitored by their physicians. This also would reduce the cost of health care and free up hospital beds for other patients.”
“In current settings, temporary pacemakers require a wire that is connected to an external generator that stimulates the heart,” Efimov said. “When the heart regains its ability to stimulate itself appropriately, the wire has to be pulled out. As you might imagine, this is a pretty dramatic procedure to pull out a wire connected to the heart. We decided to approach this problem from a different angle. We created a pacemaker that simply dissolves and does not need to be removed. This avoids the dangerous step of pulling out the wire.”
“Current pacemakers are quite intelligent and respond well to the changing needs of the patients,” Arora said. “But the wearable modules do everything traditional pacemakers do and more. A patient basically wears a little patch on their chest and gets real-time feedback to control the pacemaker. Not only is the pacemaker itself bioresorbable, it is controlled by a soft, wearable patch that allows the pacemaker to respond to the usual activities of life without needing implantable sensors.”
Rogers is also director of the Querrey Simpson Institute for Bioelectronics (QSIB). Efimov is also professor of of Medicine in the Division of Cardiology. Arora is also co-director of the Center for Arrhythmia Research.
‘Body-area network’
A bioelectronics pioneer, Rogers and his lab have been developing soft, flexible, wireless wearable devices and bioresorbable electronic technologies for nearly two decades. In the new study, Rogers and his collaborators combined and coordinated their bioresorbable, leadless pacemaker with four different skin-interfaced devices to work together. The skin-mounted devices are soft, flexible and can be gently peeled off after use, eliminating the need for surgical removal. The pacemaker naturally dissolves in the body after a period of need.
The “body-area network” includes:
- A battery-free transient, bioresorbable pacemaker to temporarily pace the heart;
- A cardiac module that sits on the chest to provide power to and control stimulation parameters for the implanted pacemaker as well as sense electrical activity and sounds of the heart;
- A hemodynamics module that sits on the forehead to sense pulse oximetry, tissue oxygenation and vascular tone;
- A respiratory module that sits at the base of the throat to monitor coughing and respiratory activity; and
- A multi-haptic-feedback module that vibrates and pulses in a variety of patterns to communicate with the patient.
“We wanted to demonstrate that it’s possible to deploy multiple different types of devices, each performing essential functions in a wirelessly coordinated manner across the body,” Rogers said. “Some are sensing. Some are delivering power. Some are stimulating. Some are providing control signals. But they all work together, trading information, making decisions based on algorithms and reacting to changing conditions. The vision of multiple bioelectronic devices all talking to one another and performing different functions at different relevant anatomical locations is a frontier area that we will continue to pursue going into the future.”
New advances, on-demand pacing
Since Northwestern’s transient pacemaker was first introduced a year ago, the scientists have made multiple improvements to advance the technology. While the previous device was flexible, the new device is flexible and stretchy, enabling it to better accommodate the changing nature of a beating heart.
The new iteration also uses a biocompatible adhesive developed in Rogers’ and Efimov’s labs. The adhesive allows the lightweight, thin device to softly laminate onto the heart’s surface without needing sutures. Another new benefit: As the transient pacemaker slowly and harmlessly dissolves, it now releases an anti-inflammatory drug to prevent foreign-body reactions.
Perhaps the most impactful advance is the device’s ability to provide pacing on-demand, based on when the patient needs it. Synced with the pacemaker, the chest-mounted cardiac module records an electrocardiogram in real time to monitor heart activity. In the study, investigators compared this wireless technology to gold-standard electrocardiograms and found it was as accurate and precise as clinical-grade systems.
“The cardiac module literally tells the pacemaker to apply stimulus to the heart,” Efimov explained. “If normal activity is regained, then it stops pacing. This is important because if you stimulate the heart when it’s unnecessary, then you risk inducing arrhythmia.”
“The pacing system is completely autonomous,” said Yeon Sik Choi, PhD, a postdoctoral fellow in the Rogers laboratory and co-lead author of the paper. “It can automatically detect a problem and apply treatment. It’s easy and self-contained with minimal external needs.”
Health care gentle enough for newborns
Rogers, Efimov, Arora and their teams believe their system would be most beneficial for the most vulnerable patients. Every year, approximately 40,000 babies are born with a hole in the wall that separates their heart’s upper chambers. About 10,000 of these cases are life threatening, requiring immediate surgery. After surgery, 100% of babies receive a temporary pacemaker.
“The good news is this is a temporary condition,” Efimov said. “After about five to seven days, the heart regains its ability to stimulate itself and no longer needs a pacemaker. The procedure to remove the pacemaker has improved greatly over the years, so the rate of complications is low. But we could free these babies from the wires connecting to an external generator and free them from needing a second procedure.”
The study, “A transient, closed-loop network of wireless, body-integrated devices for autonomous electrotherapy,” was supported by the Leducq Foundation (project RHYTHM and award number R01-HL141470), the American Heart Association (award number 19PRE34380781), the National Science Foundation (award number 1842165) and the National Institutes of Health (award number 5K99-HL148523-02). The paper’s co-lead authors are Yeon Sik Choi, Hyoyoung Jeong, PhD, and Rose Yin, PhD.
